Press Release: Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Elsevier<%2Fa>,%20a%20world-leading%20provider%20of%20scientific,%20technical%20and%20medical%20information%20products%20and%20services,%20announced%20today%20the%20acquisition%20of InferMed<%2Fa>,%20a%20London-based%20clinical%20decision%20support%20(CDS)%20technology%20company.%0D%0A%0D%0Ahttps%3A%2F%2Fwww.bookbusinessmag.com%2Farticle%2Felsevier-acquires-infermed-provider-clinical-decision-support-technology%2F" target="_blank" class="email" data-post-id="19565" type="icon_link">
Email
Email
0 Comments
Comments
Philadelphia, PA, July 1, 2015 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the acquisition of InferMed, a London-based clinical decision support (CDS) technology company.
InferMed's Arezzo technology supports clinicians in choosing the most appropriate treatment path for each patient. Arezzo matches appropriate evidence-based guidelines with patient information and dynamically evaluates best-practice options in the light of current patient and disease information. Arezzo helps physicians improve care outcomes while taking unnecessary costs out of the system.
0 Comments
View Comments
- People:
- Jay Katzen
- Robert Dunlop
- Places:
- London
- PHILADELPHIA, PA
- UK
Related Content
Comments